A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens

Author： Kosmas Christos   Tsavaris Nicolas   Syrigos Konstantinos   Koutras Angelos   Tsakonas George   Makatsoris Thomas   Mylonakis Nicolas   Karabelis Athanasios   Stathopoulos George   Kalofonos Haralambos  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.59, Iss.1, 2007-01, pp. : 51-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

By Mori Kiyoshi   Kamiyama Yukari   Kondo Tetsuro   Kano Yasuhiko   Kodama Tetsuro  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of bi-weekly paclitaxel and gemcitabine as second-line therapy for patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

By Koizumi Tomonobu   Yoshiike Fumiaki   Inou Hitoshi   Hatayama Orie   Sasabayashi Mari   Tsushima Kenji   Yamamoto Hiroshi   Hayasaka Muneharu   Kubo Keishi  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 133-138

Humana Press, Inc

Access to resources Recommend Favorite

Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens

By Kosmas C.   Tsavaris N.   Panopoulos C.   Vadiaka M.   Stavroyianni N.   Kourelis T.   Malamos N.   Antonopoulos M.   Kalofonos H.P.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 972-978

Elsevier

Access to resources Recommend Favorite

Second-line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: A phase II trial

By Tas Faruk   Demir Cumhur   Camlica Hakan   Ustuner Zeki   Topuz Erkan  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 233-240

Humana Press, Inc

Access to resources Recommend Favorite

Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study

By Seto Takashi   Takezako Yoriko   Nakamura Hiroko   Takeda Kayo   Inoue Fumiko   Semba Hiroshi   Eguchi Kenji  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 378-382

Springer Publishing Company

Access to resources Recommend Favorite